BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

ProTrials Research, Inc. Expands International Study Experience, Therapeutic Expertise and Corporate Footprint


6/15/2011 8:28:20 AM

SUNNYVALE, CA--(Marketwire - June 14, 2011) -

Now celebrating its 15th anniversary, ProTrials Research™, Inc. (www.protrials.com), a leader in the clinical research organization (CRO) industry, continues its rapid expansion with the addition of international studies in Spain and Italy and the completion of its company headquarters relocation to Sunnyvale, CA. Recognized as one of the top women-owned businesses in Silicon Valley and one of a select few U.S.-based CROs operated by women, ProTrials has now successfully completed more than 350 clinical trials conducted throughout North America, Europe and the Pacific Rim.

Significant company milestones include:

  • the completion of a large, 600-site cardiovascular study involving 5,500 patients
  • the expansion of its range of expertise in ophthalmology studies, including the completion of a study involved in a successful BLA (Biologic License Application) submission and several studies resulting in FDA approval of a major ophthalmology compound
  • staffing increase to 100 professionals averaging 15+ years of clinical trial experience

"Throughout our growth spurt, we've continued to focus on our core values: service, quality and experience," said Jodi Andrews, CEO of ProTrials. "As a result, we now offer our increasing roster of sponsors significant expertise in many therapeutic areas, particularly cardiovascular, oncology, immunology and ophthalmology. Going forward, we will continue to expand on this, as well as our international service range and staffing."

ProTrials regularly participates in industry-wide educational events. Visitors to the 47th Annual Meeting of the Drug Information Association (DIA 2011), being held June 19-23 McCormick Place in Chicago, can learn more about the company in Booth 901.

About ProTrials Research, Inc.
Founded in 1996, ProTrials Research, Inc. is a specialized contract research organization (CRO) with regional clinical research associates and project managers based throughout North America, Canada, and Europe. The company works with clients in the pharmaceutical, biotechnology and medical device industries, providing cost-effective site monitoring, project management and associated clinical operations services. ProTrials is headquartered in Sunnyvale, California. For more information, visit www.protrials.com or call (650) 864-9180.


Contact:
Rachel V. Berry
VOXUS, Inc.
253-444-5441
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES